1,300
Participants
Start Date
December 30, 2020
Primary Completion Date
December 30, 2025
Study Completion Date
December 30, 2025
Optimization of Plasma Circulating Free-DNA (cfDNA) Marker Panel
Evaluate the performance of a preliminary panel of biomarkers
RECRUITING
Mid Hudson Medical Research, New Windsor
COMPLETED
Frontier Clinical Research, Uniontown
RECRUITING
University of Pennsylvania, Philadelphia
COMPLETED
Fox Chase Cancer Center, Philadelphia
COMPLETED
Gastroenterology Consultants of SW Virginia, Roanoke
COMPLETED
Center for Gastrointestinal Disorders, Hollywood
RECRUITING
Lakeland Regional Cancer Center, Lakeland
COMPLETED
Clinical Trials Network, Union City
RECRUITING
Springfield Clinic, Springfield
COMPLETED
Ochsner Clinic, New Orleans
COMPLETED
Vilo Research Group, Houston
COMPLETED
Precision Recearch Institute, Chula Vista
COMPLETED
Precision Research Institute, San Diego
COMPLETED
Medical Associates Research Group, San Diego
COMPLETED
Clinical Research of California, Walnut Creek
COMPLETED
Dana Farber Cancer Institute, Boston
Lead Sponsor
Universal Diagnostics
INDUSTRY